Correction to: Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)

Josep M. Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G. Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S. Finn

doi:https://doi.org/10.1038/s41572-024-00500-6

Correction to: Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)

Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman-Rossi, Richard S. Finn

Department of Immunology and Cancer Research

The Hebrew University of Jerusalem

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-020-00240-3, published online 21 January 2021. In the version of this article initially published, there was an error in Table 2: the second-to-last entry under Other outcomes, now reading “44 vs 30 months (Represents 5-year median recurrence-free survival),” appeared as “65% vs 70% (Represents 5-year progression-free survival)”. The table has been corrected in the HTML and PDF versions of the article.

Original language	English
Article number	10
Journal	Nature Reviews Disease Primers
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41572-024-00500-6
State	Published - 12 Feb 2024

All Science Journal Classification (ASJC) codes

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1038/s41572-024-00500-6

Cite this

@article{6416f6b19fa547f0975c0cabab8de183,

title = "Correction to: Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)",

abstract = "Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-020-00240-3, published online 21 January 2021. In the version of this article initially published, there was an error in Table 2: the second-to-last entry under Other outcomes, now reading “44 vs 30 months (Represents 5-year median recurrence-free survival),” appeared as “65% vs 70% (Represents 5-year progression-free survival)”. The table has been corrected in the HTML and PDF versions of the article.",

author = "Llovet, {Josep M.} and Kelley, {Robin Kate} and Augusto Villanueva and Singal, {Amit G.} and Eli Pikarsky and Sasan Roayaie and Riccardo Lencioni and Kazuhiko Koike and Jessica Zucman-Rossi and Finn, {Richard S.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2024.",

year = "2024",

month = feb,

day = "12",

doi = "https://doi.org/10.1038/s41572-024-00500-6",

language = "الإنجليزيّة",

volume = "10",

journal = "Nature Reviews Disease Primers",

issn = "2056-676X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)

AU - Llovet, Josep M.

AU - Kelley, Robin Kate

AU - Villanueva, Augusto

AU - Singal, Amit G.

AU - Pikarsky, Eli

AU - Roayaie, Sasan

AU - Lencioni, Riccardo

AU - Koike, Kazuhiko

AU - Zucman-Rossi, Jessica

AU - Finn, Richard S.

PY - 2024/2/12

Y1 - 2024/2/12

N2 - Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-020-00240-3, published online 21 January 2021. In the version of this article initially published, there was an error in Table 2: the second-to-last entry under Other outcomes, now reading “44 vs 30 months (Represents 5-year median recurrence-free survival),” appeared as “65% vs 70% (Represents 5-year progression-free survival)”. The table has been corrected in the HTML and PDF versions of the article.

AB - Correction to: Nature Reviews Disease Primershttps://doi.org/10.1038/s41572-020-00240-3, published online 21 January 2021. In the version of this article initially published, there was an error in Table 2: the second-to-last entry under Other outcomes, now reading “44 vs 30 months (Represents 5-year median recurrence-free survival),” appeared as “65% vs 70% (Represents 5-year progression-free survival)”. The table has been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85185141538&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41572-024-00500-6

DO - https://doi.org/10.1038/s41572-024-00500-6

M3 - تعليقَ / نقاش

C2 - 38346997

SN - 2056-676X

VL - 10

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

IS - 1

M1 - 10

ER -

Correction to: Hepatocellular carcinoma (Nature Reviews Disease Primers, (2021), 7, 1, (6), 10.1038/s41572-020-00240-3)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this